Under-Representation of Black and Hispanic Men in Metastatic Castration-Resistant Prostate Cancer Trials (2005-2021): A Call to Action
Racial and ethnic under-representation in mCRPC trials has remained profound and, in some cases, worsened, despite increasing awareness. These findings underscore a critical need for structural reforms in trial design, funding, and regulatory oversight to ensure equitable access and generalizability of prostate cancer therapies.
Authors
- Venkatesh Gondhi
- Michael Maroules
- Canan Dirican (ORCID: https://orcid.org/0009-0008-6132-7759)
- Sagar Patel (ORCID: https://orcid.org/0000-0001-6670-851X)
- Amara Sofia (ORCID: https://orcid.org/0009-0001-1075-7504)
- B Fernandes (ORCID: https://orcid.org/0000-0002-4312-2978)
- Ahmad Mardini
Institutions
- University of Saint Mary (US)
- St. Mary's Hospital (US)
- Saint Michael's Medical Center (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1200/op-25-00827
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52